Compare stocks

Agfa-Gevaert NV is a Belgium-based company specializing in imaging technology for various industries, including healthcare, printing, and materials. Its primary segments include Radiology Solutions, which offers diagnostic imaging products like direct radiography and traditional X-ray systems, and Digital Print & Chemicals, focusing on industrial applications such as printing plates and synthetic papers. Founded in 1867, the company has a long history in photographic film production, although it has since diversified its offerings. Agfa-Gevaert is headquartered in Mortsel, Belgium, and operates globally, serving customers in a wide range of markets. The company's strategic strengths lie in its technological expertise and well-established brand reputation within its niche sectors.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.